|[February 04, 2013]
HiFocus Mid-Scala Electrode from Advanced Bionics Receives Approval in Europe
VALENCIA, Calif. --(Business Wire)--
Bionics (AB), a global leader in cochlear implant technology and a
company of the Sonova Group, announced today that it received T�V
approval in Europe for the HiFocus™ Mid-Scala* electrode. The latest
offering in AB's HiFocus™ electrode family, the HiFocus Mid-Scala is
designed to help protect the delicate structures of the cochlea for the
preservation of residual hearing without compromising performance.
HiFocus(TM) Mid-Scala Electrode from Advanced Bionics (Photo: Business Wire)
The new HiFocus Mid-Scala array is the latest innovation in electrode
design. Developed through extensive research and state-of-the-art
manufacturing processes, the HiFocus Mid-Scala electrode has been
designed for optimal mid-scala placement in the cochlea to protect its
delicate structures and preserve residual hearing. It is fully
upgradeable for next-generation sound processing and provides recipients
with the opportunity to enjoy the best possible hearing now and improved
hearing in the future as new technology is introduced.
"For anyone with significant hearing loss, the preservation of any
hearing that remains is important when getting a cochlear implant," said
Hansjuerg Emch, Group Vice President of the Sonova Medical Division
within which AB resides. "At the same time, we need to ensure that the
electrode position in the cochlea enables the best possible electrical
stimulation of the hearing nerve. We developed the HiFocus Mid-Scala
electrode to do just that."
Featuring the industry's smallest pre-curved array, the HiFocus
Mid-Scala is the only pre-curved electrode developed for the latest soft
surgery approaches, including round window insertion, to suit surgeon
preferences and individual recipient needs.
"The HiFocus Mid-Scala is truly the industry's first and only electrode
developed for a variety of surgical approaches. We are proud to provide
surgeons with unparalleled flexibility to suit their preferred
techniques," said Mark Downing, Director of Product Management and
Surgical Support. "With this approval, surgeons across Europe now have
three advanced electrode options to choose from that best meet the needs
of their patients."
The new Mid-Scala model, like every electrode array in the HiFocus line,
delivers AB's proprietary current steering technology for hearing that
more closely resembles normal hearing.
The HiFocus Mid-Scala electrode, HiRes 90K™ Advantage implant, and
current steering are just a few of many industry firsts delivered by AB
to provide recipients with better hearing through the most advanced
technology. AB has developed unsurpassed sound processing strategies
designed to provide the best hearing performance in real-world settings,
Fidelity 120™**, and AutoSound.
The company also recently introduced Neptune™,
the world's first and only swimmable sound processor, which continues to
make a big splash in many countries across the world.
For more information about the HiFocus Mid-Scala electrode, or any
Advanced Bionics product, contact a local AB representative or visit AdvancedBionics.com.
About Advanced Bionics
Advanced Bionics is a global leader in developing the most
advanced cochlear implant systems in the world. Founded in 1993 and a
subsidiary of the Sonova Group since 2009, AB develops cutting-edge
cochlear implant technology that allows recipients to hear their best.
AB offers the most sophisticated cochlear implant system on the market,
the HiResolution™ Bionic Ear System, with five times more
sound resolution than its competitors, designed to help recipients hear
in noisy settings and enjoy the full dimensions of music.
With sales in over 50 countries and a proven track record for developing
high-performing, state-of-the-art products, AB's talented group of
technologists and professionals from all over the world are driven to
succeed, work with integrity and stay firmly committed to quality.
To learn more about AB and its innovative cochlear implant technology,
please visit AdvancedBionics.com.
*Pending regulatory approval in the United States and Canada.
**Not approved for pediatric use in the United States.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130204006653/en/
[ InfoTech Spotlight's Homepage ]